Literature DB >> 22496368

Signal transducer and activator of transcription 3 (STAT3) protein suppresses adenoma-to-carcinoma transition in Apcmin/+ mice via regulation of Snail-1 (SNAI) protein stability.

Jongdae Lee1, Joanna C K Kim, Shee-Eun Lee, Christine Quinley, HyeRi Kim, Scott Herdman, Maripat Corr, Eyal Raz.   

Abstract

STAT3 was recently reported to suppress tumor invasion in Apc(min)(/+) mice. We investigated the mechanisms by which STAT3 inhibits intestinal epithelial tumors using Apc(min)(/+)/Stat3(IEC-KO) mice (intestinal epithelial cell (IEC)-specific deletion of STAT3 in the Apc(min)(/+) background) to determine the role of STAT3 in carcinogenesis in vivo as well as colorectal cancer cell lines in vitro. To inhibit invasion of IEC tumors, STAT3 functions as a molecular adaptor rather than a transcription factor. Accordingly, the tumors in Apc(min)(/+)/Stat3(IEC-KO) mice undergo adenoma-to-carcinoma transition and acquire an invasive phenotype. Similarly, STAT3 knockdown in a colorectal cell line enhances IEC invasion. We demonstrate that STAT3 down-regulates SNAI (Snail-1) expression levels and hence suppresses epithelial-mesenchymal transition of colorectal cancer cells. Mechanistically, STAT3 facilitates glycogen synthase kinase (GSK) 3β-mediated degradation of SNAI by regulating phosphorylation of GSK3β. Our data identified a new role for STAT3 in the adenoma-to-carcinoma sequence of intestinal tumors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22496368      PMCID: PMC3365759          DOI: 10.1074/jbc.M111.328831

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

Review 1.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

2.  Expression of p-STAT3 in human colorectal adenocarcinoma and adenoma; correlation with clinicopathological factors.

Authors:  T Kusaba; T Nakayama; K Yamazumi; Y Yakata; A Yoshizaki; T Nagayasu; I Sekine
Journal:  J Clin Pathol       Date:  2005-08       Impact factor: 3.411

3.  EphB receptor activity suppresses colorectal cancer progression.

Authors:  Eduard Batlle; Julinor Bacani; Harry Begthel; Suzanne Jonkheer; Suzanne Jonkeer; Alexander Gregorieff; Maaike van de Born; Núria Malats; Elena Sancho; Elles Boon; Tony Pawson; Steven Gallinger; Steven Pals; Hans Clevers
Journal:  Nature       Date:  2005-06-23       Impact factor: 49.962

4.  Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells.

Authors:  Jongdae Lee; Ji-Hun Mo; Kyoko Katakura; Irit Alkalay; Adam N Rucker; Yu-Tsueng Liu; Hyun-Ku Lee; Carol Shen; Gady Cojocaru; Steve Shenouda; Martin Kagnoff; Lars Eckmann; Yinon Ben-Neriah; Eyal Raz
Journal:  Nat Cell Biol       Date:  2006-11-26       Impact factor: 28.824

5.  The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells.

Authors:  Ofelia M Martínez-Estrada; Albert Cullerés; Francesc X Soriano; Hector Peinado; Victoria Bolós; Fernando O Martínez; Manuel Reina; Amparo Cano; Myriam Fabre; Senén Vilaró
Journal:  Biochem J       Date:  2006-03-01       Impact factor: 3.857

6.  Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation.

Authors:  Tina M Thornton; Gustavo Pedraza-Alva; Bin Deng; C David Wood; Alexander Aronshtam; James L Clements; Guadalupe Sabio; Roger J Davis; Dwight E Matthews; Bradley Doble; Mercedes Rincon
Journal:  Science       Date:  2008-05-02       Impact factor: 47.728

7.  gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.

Authors:  Julia Bollrath; Toby J Phesse; Vivian A von Burstin; Tracy Putoczki; Moritz Bennecke; Trudie Bateman; Tim Nebelsiek; Therese Lundgren-May; Ozge Canli; Sarah Schwitalla; Vance Matthews; Roland M Schmid; Thomas Kirchner; Melek C Arkan; Matthias Ernst; Florian R Greten
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

8.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

9.  Significance of p-STAT3 expression in human colorectal adenocarcinoma.

Authors:  Jae-Kyoung Park; Ran Hong; Kyung-Jong Kim; Tae-Bum Lee; Sung-Chul Lim
Journal:  Oncol Rep       Date:  2008-09       Impact factor: 3.906

10.  Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin.

Authors:  Dominic Chi Hiung Ng; Bao Hong Lin; Cheh Peng Lim; Guochang Huang; Tong Zhang; Valeria Poli; Xinmin Cao
Journal:  J Cell Biol       Date:  2006-01-09       Impact factor: 10.539

View more
  35 in total

Review 1.  STAT3 in hepatocellular carcinoma: new perspectives.

Authors:  Jasmin Svinka; Wolfgang Mikulits; Robert Eferl
Journal:  Hepat Oncol       Date:  2013-12-20

2.  STAT3 integrates cooperative Ras and TGF-β signals that induce Snail expression.

Authors:  M Saitoh; K Endo; S Furuya; M Minami; A Fukasawa; T Imamura; K Miyazawa
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

3.  Chemerin reverses the malignant phenotype and induces differentiation of human hepatoma SMMC7721 cells.

Authors:  Ming Li; Pengcheng Sun; Kaikai Dong; Ye Xin; Aslee TaiLulu; Qinyu Li; Jing Sun; Min Peng; Ping Shi
Journal:  Arch Pharm Res       Date:  2021-01-27       Impact factor: 4.946

4.  MicroRNA-155 deletion promotes tumorigenesis in the azoxymethane-dextran sulfate sodium model of colon cancer.

Authors:  Kandy T Velázquez; Reilly T Enos; Jamie L McClellan; Taryn L Cranford; Ioulia Chatzistamou; Udai P Singh; Mitzi Nagarkatti; Prakash S Nagarkatti; Daping Fan; E Angela Murphy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-01-07       Impact factor: 4.052

5.  Ion channel TRPV1-dependent activation of PTP1B suppresses EGFR-associated intestinal tumorigenesis.

Authors:  Petrus R de Jong; Naoki Takahashi; Alexandra R Harris; Jihyung Lee; Samuel Bertin; James Jeffries; Michael Jung; Jen Duong; Amy I Triano; Jongdae Lee; Yaron Niv; David S Herdman; Koji Taniguchi; Chang-Whan Kim; Hui Dong; Lars Eckmann; Stephanie M Stanford; Nunzio Bottini; Maripat Corr; Eyal Raz
Journal:  J Clin Invest       Date:  2014-08-01       Impact factor: 14.808

Review 6.  Role of STAT3 in lung cancer.

Authors:  Pranabananda Dutta; Nafiseh Sabri; Jinghong Li; Willis X Li
Journal:  JAKSTAT       Date:  2015-01-20

7.  Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc (Min/+) mouse model.

Authors:  Yu-Sheng Zhang; Ye Li; Yan Wang; Shi-Yue Sun; Tao Jiang; Cong Li; Shu-Xiang Cui; Xian-Jun Qu
Journal:  J Cancer Res Clin Oncol       Date:  2015-12-24       Impact factor: 4.553

8.  GNAQ knockdown promotes bone metastasis through epithelial-mesenchymal transition in lung cancer cells.

Authors:  Ji-Yoon Choi; Yun Sun Lee; Da Mi Shim; Young Keun Lee; Sung Wook Seo
Journal:  Bone Joint Res       Date:  2021-05       Impact factor: 5.853

9.  Potential Refinement of Recurrence Score by pSTAT3 Status.

Authors:  Albert Grinshpun; Yogev Cohen; Aviad Zick; Luna Kadouri; Tamar Hamburger; Benjamin Nisman; Tanir M Allweis; Gabriela Oprea; Tamar Peretz; Beatrice Uziely; Amir Sonnenblick
Journal:  Genes (Basel)       Date:  2022-02-27       Impact factor: 4.096

Review 10.  The dual role of inflammation in colon carcinogenesis.

Authors:  Giovanni Monteleone; Francesco Pallone; Carmine Stolfi
Journal:  Int J Mol Sci       Date:  2012-09-06       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.